Continuous subcutaneous infusion of Remodulin™, a prostacyclin analogue, in patients with pulmonary arterial hypertension:: Long-term outcome

被引：0
|
作者：
McLaughlin, V
Sitbon, O
Sigman, J
Blackburn, S
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Hop Antoine Beclere, Clamart, France
[3] United Therapeut Corp, Res Triangle Pk, NC USA
[4] United Therapeut Corp, Remodulin Study Grp, Res Triangle Pk, NC USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [41] Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Okano, Yoshiaki
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Hatta, Motonori
    Sasayama, Shigetake
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 921 - 928
  • [42] Long-term survival of systemic sclerosis with pulmonary arterial hypertension patients
    Sirijanchune, Piyaporn
    Lhakum, Panomkorn
    RESPIROLOGY, 2023, 28 : 26 - 27
  • [43] Long-term effects with ambrisentan monotherapy in patients with pulmonary arterial hypertension
    文莉
    ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (03) : 160 - 161
  • [44] Long-Term Epoprostenol Infusion Therapy Could Induce Hyperthyroidism in Patients With Idiopathic and Hereditary Pulmonary Arterial Hypertension
    Funasako, Moritoshi
    Miyaji, Katsumasa
    Sakuma, Masahito
    Takagi, Yaemi
    Kyotani, Shingo
    Nakanishi, Norifumi
    CIRCULATION, 2010, 122 (21)
  • [45] TRANSITION FROM PROSTACYCLIN ANALOGUE INFUSION TO ORAL THERAPY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: A FIVE YEAR FOLLOW-UP
    Pineda, Andres M.
    Escolar, Esteban
    Correal, Barbara
    Ahmed, Tahir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1250 - E1250
  • [46] Long-term subcutaneous treprostinil therapy evokes both survival benefits and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension
    Vachiery, JL
    Gautier, MT
    Huez, S
    Retailleau, K
    Naeije, R
    CIRCULATION, 2003, 108 (17) : 400 - 400
  • [47] LONG TERM SURVIVAL AND TRANSPLANT RATES IN PULMONARY ARTERIAL HYPERTENSION PATIENTS TREATED WITH PARENTERAL PROSTACYCLIN THERAPY
    Ghosh, Sudeshna
    Shah, Trushil
    Bartolome, Sonja
    Gordon, Rhoda Annoh
    Chin, Kelly
    CHEST, 2020, 158 (04) : 2262A - 2263A
  • [48] Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management
    Shapiro, Shelley
    Traiger, Glenna L.
    Turner, Michelle
    McGoon, Michael D.
    Wason, Prieya
    Barst, Robyn J.
    CHEST, 2012, 141 (02) : 363 - 373
  • [49] Long-Term Intravenous Iloprost In Pulmonary Arterial Hypertension
    Ramjug, S.
    Hussain, N.
    Hamilton, N.
    Hurdman, J.
    Billings, C. G.
    Elliot, C.
    Kiely, D.
    Condliffe, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [50] Long-term therapeutic outcomes in pulmonary arterial hypertension
    Galie, Nazzareno
    Hirani, Naushad
    Manes, Alessandra
    Romanazzi, Serena
    Palazzini, Massimiliano
    Negro, Luca
    Branzi, Angelo
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S11 - S18
12345